Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 10/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | CTSD | P07339 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9545572 | 0.89 | CCKBR (0.42) | CCKBRBACE1BACE2 | |
| SCHEMBL9545602 | 0.84 | CCKBR (0.42) | CCKBRKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL9545585 | 0.81 | CCKBR (0.40) | CCKBRBACE1BACE2 | |
| SCHEMBL9545566 | 0.79 | CCKBR (0.44) | CCKBRBACE1BACE2 | |
| SCHEMBL9301948 | 0.77 | CCKBR (0.41) | CCKBRALDH1A1APPCTSDBACE1 | |
| SCHEMBL9303570 | 0.74 | CCKBR (0.45) | CCKBRALDH1A1 | |
| SCHEMBL9545573 | 0.73 | CCKBR (0.78) | CCKBR | |
| SCHEMBL9218194 | 0.72 | CCKBR (0.35) | CCKBRAPPCTSDBACE1BACE2 | |
| SCHEMBL9699964 | 0.72 | CCKBR (0.45) | CCKBRALDH1A1BACE1BACE2 | |
| SCHEMBL9301587 | 0.71 | CCKBR (0.57) | CCKBRBACE1BACE2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993019052-A1 | 3-UREIDO SUBSTITUTED BENZODIAZEPIN-2-ONES HAVING CHOLECYSTOKININ AND/OR GASTRIN ANTAGONISTIC ACTIVITY AND THEIR USE IN THERAPY | MERCK SHARP & DOHME LIMITED (GB) | 1993-09-30 | — | — | WO | claimed |
| WO-1993019052-A1 | 3-UREIDO SUBSTITUTED BENZODIAZEPIN-2-ONES HAVING CHOLECYSTOKININ AND/OR GASTRIN ANTAGONISTIC ACTIVITY AND THEIR USE IN THERAPY | MERCK SHARP & DOHME LIMITED (GB) | 1993-09-30 | — | — | WO | disclosed |